NEXT Oncology is a clinical research site located in Irving, Texas, United States 75039.
Crixeo Clinical Trials Trust Score: 79/100 (FAIR). This profile has not yet been claimed by the site owner.
NEXT Oncology has participated in 13 clinical trials with 11 currently active.
Therapeutic areas: Solid Tumor, Cancer, Advanced-stage Solid Tumors.
Sponsors: Boundless Bio, Inc., MBrace Therapeutics, Janssen Research & Development, LLC.
Trust Score: 79/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
NEXT Oncology has a Crixeo Trust Score of 79/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
NEXT Oncology has 13 clinical trials on record, with 11 currently active. Their work covers Solid Tumor, Cancer, Advanced-stage Solid Tumors.
NEXT Oncology has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.